UCHL1 and CD4+/CD56+ hematodermic neoplasm: Next, to evaluate the presence of neural cells in BPDCN, antibodies anti—doublecortin (DCX), and Ubiquitin C-terminal hydrolase 1 (UCHL-1) were used.